- Home
- TGB vs CRMD Comparison
TGB vs CRMD Comparison
Compare TGB & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGB
- CRMD
- Stock Information
- Founded
- TGB 1966
- CRMD 2006
- Country
- TGB Canada
- CRMD United States
- Employees
- TGB N/A
- CRMD N/A
- Industry
- TGB Precious Metals
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- TGB Basic Materials
- CRMD Health Care
- Exchange
- TGB Nasdaq
- CRMD Nasdaq
- Market Cap
- TGB 633.3M
- CRMD 626.8M
- IPO Year
- TGB N/A
- CRMD 2010
- Fundamental
- Price
- TGB $2.08
- CRMD $10.33
- Analyst Decision
- TGB Strong Buy
- CRMD Strong Buy
- Analyst Count
- TGB 1
- CRMD 5
- Target Price
- TGB $3.50
- CRMD $15.20
- AVG Volume (30 Days)
- TGB 5.6M
- CRMD 1.6M
- Earning Date
- TGB 11-06-2024
- CRMD 10-30-2024
- Dividend Yield
- TGB N/A
- CRMD N/A
- EPS Growth
- TGB 17.58
- CRMD N/A
- EPS
- TGB 0.12
- CRMD N/A
- Revenue
- TGB $439,681,705.00
- CRMD $12,262,234.00
- Revenue This Year
- TGB $19.57
- CRMD N/A
- Revenue Next Year
- TGB $15.05
- CRMD $277.75
- P/E Ratio
- TGB $17.83
- CRMD N/A
- Revenue Growth
- TGB 25.87
- CRMD 41184.20
- 52 Week Low
- TGB $1.15
- CRMD $2.89
- 52 Week High
- TGB $3.15
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- TGB 42.31
- CRMD 47.20
- Support Level
- TGB $1.95
- CRMD $10.16
- Resistance Level
- TGB $2.12
- CRMD $11.41
- Average True Range (ATR)
- TGB 0.12
- CRMD 0.73
- MACD
- TGB -0.02
- CRMD -0.18
- Stochastic Oscillator
- TGB 20.97
- CRMD 31.00
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.